Cargando…

Physicochemical characterization of biological and synthetic forms of two lipid A-based TLR4 agonists

Toll-like receptor (TLR) agonists are recognized as potential immune-enhancing adjuvants and are included in several licensed vaccines. Monophosphoryl lipid A (MPL®, GlaxoSmithKline) is one such TLR4 agonist that has been approved for use in human vaccines, such as Cervarix and Shingrix. Due to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Gang, Varisco, David J., Das, Sayan, Middaugh, C. Russell, Gardner, Francesca, Ernst, Robert K., Picking, Wendy L., Picking, William D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362264/ https://www.ncbi.nlm.nih.gov/pubmed/37483830 http://dx.doi.org/10.1016/j.heliyon.2023.e18119

Ejemplares similares

Impact of the TLR4 agonist BECC438 on a novel vaccine formulation against Shigella spp.
por: Lu, Ti, et al.
Publicado: (2023)

Effect of Two Unique Nanoparticle Formulations on the Efficacy of a Broadly Protective Vaccine Against Pseudomonas Aeruginosa
por: Howlader, Debaki R., et al.
Publicado: (2021)

Preformulation Characterization and the Effect of Ionic Excipients on the Stability of a Novel DB Fusion Protein
por: Jain, Akshay, et al.
Publicado: (2020)

A protein subunit vaccine elicits a balanced immune response that protects against Pseudomonas pulmonary infection
por: Howlader, Debaki R., et al.
Publicado: (2023)

Immunogenicity and protective efficacy of nanoparticle formulations of L-SseB against Salmonella infection
por: Das, Sayan, et al.
Publicado: (2023)

The Many Faces of IpaB
por: Picking, Wendy L., et al.
Publicado: (2016)

The Shigella Type III Secretion System: An Overview from Top to Bottom
por: Muthuramalingam, Meenakumari, et al.
Publicado: (2021)

Development of a Broadly Protective, Self-Adjuvanting Subunit Vaccine to Prevent Infections by Pseudomonas aeruginosa
por: Das, Sayan, et al.
Publicado: (2020)

Vaccination With Mouse Dendritic Cells Loaded With an IpaD-IpaB Fusion Provides Protection Against Shigellosis
por: Arizmendi, Olivia, et al.
Publicado: (2019)

Expression, purification, crystallization and preliminary crystallographic analysis of MxiH, a subunit of the Shigella flexneri type III secretion system needle
por: Deane, Janet E., et al.
Publicado: (2006)

Expression, limited proteolysis and preliminary crystallographic analysis of IpaD, a component of the Shigella flexneri type III secretion system
por: Johnson, Steven, et al.
Publicado: (2006)

Förster Resonance Energy Transfer (FRET) as a Tool for Dissecting the Molecular Mechanisms for Maturation of the Shigella Type III Secretion Needle Tip Complex
por: Dickenson, Nicholas E., et al.
Publicado: (2012)

Composition and Biophysical Properties of the Sorting Platform Pods in the Shigella Type III Secretion System
por: Tachiyama, Shoichi, et al.
Publicado: (2021)

Evidence for alternative quaternary structure in a bacterial Type III secretion system chaperone
por: Barta, Michael L, et al.
Publicado: (2010)

In vivo characterization of the physicochemical properties of TLR agonist delivery that enhance vaccine immunogenicity
por: Lynn, Geoffrey M., et al.
Publicado: (2015)

Physicochemical considerations for bottom-up synthetic biology
por: Śmigiel, Wojciech Mikołaj, et al.
Publicado: (2019)

A Smart Kitchen for Ambient Assisted Living
por: Blasco, Rubén, et al.
Publicado: (2014)

Factors Associated with Delayed Paracentesis in Patients with Spontaneous Bacterial Peritonitis
por: Abdu, Backer, et al.
Publicado: (2020)

Solid Lipid Nanoparticle Carrier Platform Containing Synthetic TLR4 Agonist Mediates Non-Viral DNA Vaccine Delivery
por: Francis, Jasmine E., et al.
Publicado: (2020)

Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists
por: Birmachu, Woubalem, et al.
Publicado: (2007)

Rasburicase-Induced Methemoglobinemia
por: Ahmed, Moeed, et al.
Publicado: (2021)

Biological and Physicochemical Functions of Ubiquitylation Revealed by Synthetic Chemistry Approaches
por: Morimoto, Daichi, et al.
Publicado: (2017)

Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection
por: Ramirez, Karina, et al.
Publicado: (2009)

Manufacturing‐dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development
por: Steeghs, Neeltje, et al.
Publicado: (2022)

Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140
por: Arias, Mauricio A., et al.
Publicado: (2012)

OMV Vaccines and the Role of TLR Agonists in Immune Response
por: Mancini, Francesca, et al.
Publicado: (2020)

Toll-Like Receptor 4 Expression on Lymphoma Cells Is Critical for Therapeutic Activity of Intratumoral Therapy With Synthetic TLR4 Agonist Glucopyranosyl Lipid A
por: Lu, Hailing, et al.
Publicado: (2020)

Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants
por: Shanmugam, Arulkumaran, et al.
Publicado: (2012)

Synthetic glycan-based TLR4 agonists targeting caspase-4/11 for the development of adjuvants and immunotherapeutics
por: Adanitsch, Florian, et al.
Publicado: (2018)

High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation
por: Gadd, Adam J.R., et al.
Publicado: (2018)

TLR4 Agonist Monophosphoryl Lipid A Alleviated Radiation-Induced Intestinal Injury
por: Guo, Jiaming, et al.
Publicado: (2019)

Inhibition of Cytochrome P450 Activities by Extracts of Hyptis verticillata Jacq.: Assessment for Potential HERB-Drug Interactions
por: Picking, David, et al.
Publicado: (2018)

Assessing Wellbeing in People Living with Dementia Using Reminiscence Music with a Mobile App (Memory Tracks): A Mixed Methods Cohort Study
por: Cunningham, Stuart, et al.
Publicado: (2019)

Deoxyguanosine is a TLR7 agonist
por: Davenne, Tamara, et al.
Publicado: (2019)

NOD2 Agonist Promotes the Production of Inflammatory Cytokines in VSMC in Synergy with TLR2 and TLR4 Agonists
por: Sun, Jinghua, et al.
Publicado: (2012)

Prevention and Mitigation of Acute Radiation Syndrome in Mice by Synthetic Lipopeptide Agonists of Toll-Like Receptor 2 (TLR2)
por: Shakhov, Alexander N., et al.
Publicado: (2012)

Physicochemical characterizations of functional hybrid liposomal nanocarriers formed using photo-sensitive lipids
por: Kumar Pramanik, Sumit, et al.
Publicado: (2017)

Molecular and Cellular Response Profiles Induced by the TLR4 Agonist-Based Adjuvant Glucopyranosyl Lipid A
por: Lambert, Stacie L., et al.
Publicado: (2012)

Comparison of human B cell activation by TLR7 and TLR9 agonists
por: Hanten, John A, et al.
Publicado: (2008)

Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists
por: Cheng, Kui, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lsumet0n49qu6faok55g5kjj62